ChemChina-Owned Syngenta Targets $10 Billion in Shanghai IPO
(Bloomberg) -- Syngenta Group, the Swiss seed and fertilizer business owned by China National Chemical Corp., is targeting to raise 65 billion yuan ($10 billion) in a Shanghai listing that could become the world's largest initial public offering this year.
Syngenta aims to list on Shanghai's Nasdaq-style Star Board, it said in a prospectus published on the stock exchange website Friday. It plans to sell as many as 2.79 billion new shares in the IPO, equivalent to a 20% stake in the company, according to the filing.
China International Capital Corp. and BOC International Holdings Ltd. are sponsors of the planned share sale, Syngenta said. Citic Securities Co. is also working on the deal.
An IPO would turn a new page for Syngenta, which went through a reorganization after ChemChina acquired the company for $43 billion in 2017, clinching China's biggest foreign takeover to date. Syngenta Group incorporated other ChemChina agricultural units including Adama Ltd. and the agriculture business of Chinese conglomerate Sinochem Corp. last year.
The listing is also a nod to China's self-sufficiency drive in food, with policy makers vowing to accelerate innovation in the seed industry under their latest five-year plan. To produce the Chinese staple foods of pork and poultry, a large amount of feed is essential. Without improving development, China would have to rely on seeds and feed grains imported from abroad.
Once wary of genetically modified crops where Syngenta has an edge, China has begun to loosen restrictions amid growing concerns about food security. GM feed grains are on the agenda for commercial production, and some strains of corn and soy for animal feed have already been approved by officials this year.
©2021 Bloomberg L.P.
-
India's Troika Of Good Luck | Joining The Dots
A weaker Trump, a cooling AI trade and resilient earnings have put Indian markets back in favour. Rising inflation could spoil the party.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.